Shengtai Pharmaceutical Inc., (OTC BB: SGTI) is China’s leading manufacturer and supplier of pharmaceutical grade glucose for medicinal purposes. In addition to their pharmaceutical glucose series of products, they also produce other medicinal product lines as well such as industrial glucose, syrup, starch, avermectins, dextrin, maltose and maltitol, which are used for food, beverage and industrial production. Based in China, Shengtai has an international client-base. For further information, visit the company website at: www.shengtaipharmaceutical.com.
- 17 years ago
QualityStocks
Shengtai Pharmaceutical Inc., (OTC BB: SGTI)
Tags Rodman & Renshaw
Related Post
-
SuperCom Ltd. (NASDAQ: SPCB) Expands European Presence with New $7 Million German Contract, Covering Multiple Programs
The electronic monitoring (“EM”) company won Germany’s national EM contract, valued at up to $7…
-
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development
Hoth Therapeutics (NASDAQ: HOTH) is using Lantern Pharma’s (NASDAQ: LTRN) PredictBBB.ai(TM) platform to accelerate development…
-
QualityStocksNewsBreaks – Big Tree Cloud Holdings Limited (NASDAQ: DSY, NASDAQ: DSYWW) Prices $5 Million Registered Direct Offering
Big Tree Cloud Holdings Limited (NASDAQ: DSY, NASDAQ: DSYWW) announced it has entered into a…